CPRX Catalyst Pharmaceuticals Inc

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. The Company is engaged in the development and commercialization of therapies for people with rare debilitating diseases.

$6.63  -0.06 (-0.90%)
As of 06/24/2022 15:59:56 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/08/2006
Outstanding shares:  102,780,151
Average volume:  1,089,169
Market cap:   $687,599,210
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B1G7Q03
Valuation   (See tab for details)
PE ratio:   15.15
PB ratio:   3.10
PS ratio:   8.45
Return on equity:   20.46%
Net income %:   55.36%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy